ClinicalTrials.gg
RecruitingNCT06990724Updated Dec 22, 2025

Effectiveness Testing of a Videogame Intervention (No Baby No) to Decrease Contraception Non-use Among Adolescents.

An interventional study of Videogame Intervention and Commercial game control in Contraceptive Usage and Contraception Behavior, sponsored by Weill Medical College of Cornell University. Recruiting at 7 sites in United States. Open to participants aged 15 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-22.

Sponsored by Weill Medical College of Cornell University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
850
Allocation
Randomized
Ages
15 Years to 20 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of a videogame compared to an attention/time control at reducing contraceptive non-use among adolescents.

02

Conditions studied

  • Contraceptive Usage
  • Contraception Behavior
03

In context

Contraception Behavior

132 studies on the registry are indexed under Contraception Behavior; 20 are open to participants now.

This study's planned enrollment of 850 is above the median of 382 across 106 interventional studies indexed under Contraception Behavior.

Browse Contraception Behavior studies →

Lead sponsor

Weill Medical College of Cornell University is the lead sponsor of 892 studies on the registry; 165 are open to participants now.

Of its 123 completed or terminated interventional studies of FDA-regulated products, 94 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or Female
  • Age15-20 at the time of enrollment
  • Able to speak and read English or Spanish
  • Have a smart phone (to scan QR code) or personal email account (to take screening questionnaire)

Exclusion criteria

Exclusion Criteria:

  • Age less than 15 or older than 20
  • Unable to speak and read English or Spanish
  • Do not have a smart phone or personal email account
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
850 participants (estimated)

Study arms

  • Experimental
    No Baby No Videogame Intervention

    Participants randomized to video game intervention for 120 minutes over two sessions within two weeks.

    Other: Videogame Intervention

  • Sham comparator
    Commercial game control

    Participants randomized to commercial game intervention for 120 minutes over two sessions within two weeks.

    Other: Commercial game control

Interventions

  • OtherVideogame Intervention

    No Baby No video game

  • OtherCommercial game control

    Commercial video game

06

What researchers measure

Primary outcomes

  1. Change in mean frequency of participants' contraception non-use over the last 3 months.

    Change in mean frequency of how often participants had penile/vaginal sex without a condom or birth control (pregnancy prevention), as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). Scale values range from once to five or more times, with higher scores indicating a "worse" outcome. Scores are not being reported. At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  2. Change in mean frequency of participants' contraception non-use at last sexual encounter.

    Change in mean frequency of how often participants had penile/vaginal sex without a condom or birth control (pregnancy prevention), as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). Scale values range from once to five or more times, with higher scores indicating a "worse" outcome. Scores are not being reported. At baseline, 2 weeks, and 9-month follow-up participants will be asked about their last sexual encounter.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  3. Change in participants' use of different types of contraception over the last 3 months.

    A change in the mean use of less effective- (withdrawal, condom with or without spermicide, spermicide alone, fertility-based awareness, diaphragm, sponge), more effective- (pill, patch, vaginal ring, injection, intrauterine device, implant), and dual method (condom + other) contraception use during sexual encounters as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). Participants select all forms of contraception that they used, with response options also including "No method was used to prevent pregnancy or STIs". At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  4. Change in participants' use of different types of contraception at last sexual encounter.

    A change in the mean use of less effective- (withdrawal, condom with or without spermicide, spermicide alone, fertility-based awareness, diaphragm, sponge), more effective- (pill, patch, vaginal ring, injection, intrauterine device, implant), and dual method (condom + other) contraception use during sexual encounters as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about their last sexual encounter.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  5. Change in number of participants abstaining from having sex over the last 3 months.

    A change in the number of participants who abstained from having sex as self-reported on a customized survey with multiple-choice questions adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  6. Change in the mean number of sexual encounters over the last 3 months.

    A change in the mean number of times participants had penile/vaginal sex as self-reported on a customized survey with a multiple-choice survey question adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  7. Change in the mean number of sexual partners over the last 3 months.

    A change in participants mean number of self-reported sexual partners, as reflected by their answer to a multiple-choice survey question adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about the prior 3 months.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  8. Change in the number of participants who use alcohol and/or take drugs before sex at last sexual encounter.

    Change in the number of participants who self-report drinking alcohol or using drugs before having sex, based on Yes/No responses to a question adapted from the Youth Risk Behavior Survey (YRBS). At baseline, 2 weeks, and 9-month follow-up participants will be asked about the last sexual encounter.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  9. Change in the number of participants with a positive STI (Sexually Transmitted infection) test result.

    A change in the number of participants who self-report ever receiving a positive STI result on a customized survey as adapted by YRBSS Questionnaire. At baseline, 2 weeks, and 9-month follow-up participants will be asked if they have ever received a positive STI (Sexually Transmitted infection) test result.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  10. Change in the number of participants with a positive pregnancy test result for themselves or a partner.

    A change in the number of participants who self-report ever receiving a positive pregnancy test result or report their partner ever receiving a positive pregnancy test result, as documented by a Yes/No question on a customized survey. At baseline, 2 weeks, and 9-month follow-up participants will be asked if they/their partner have ever received a positive pregnancy test result.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

Secondary outcomes

  1. Change in participants' intentions for contraception non-use over the next year, as indicated by participants' mean responses to a survey question.

    A change in the mean Likert-scale rating of participants on a survey item asking about their commitment to using contraception adapted from existing literature. At baseline, 2 weeks, and 9-month follow-up participants will be asked about their commitment to using contraception.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  2. Change in participants' self-efficacy regarding condom use, as indicated by their mean rating on a survey question.

    A change in the mean 5-point Likert-scale rating (anchor points "I strongly agree" to "I strongly disagree") on a survey item by participants reflecting their degree of confidence in correctly and consistently using condoms. The survey question is adapted from existing literature. At baseline, 2 weeks, and 9-month follow-up participants will be asked about their confidence in condom usage.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  3. Change in participants' self-efficacy regarding contraception use, as indicated by their mean ratings on a survey question.

    A change in the mean survey-item rating by participants reflecting their degree of confidence in correctly and consistently using contraception using a question adapted from existing literature. At baseline, 2 weeks, and 9-month follow-up participants will be asked about their confidence in contraception use.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  4. Change in participants' perceptions of sexual risk (susceptibility to getting an STI), as indicated by their mean rating on a survey question.

    A change in the mean survey-item rating by participants reflecting their perceived likelihood of getting an STI, based on contraception non-use, using a question adapted from existing literature. At baseline, 2 weeks, and 9-month follow-up participants will be asked of their perceived likelihood of getting an STI.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  5. Change in participants' perceptions of sexual risk (getting pregnant/getting a partner pregnant), as indicated by their mean rating on a survey question.

    A change in the mean survey-item rating by participants reflecting their perceived likelihood of getting pregnant (or getting a partner pregnant), based on contraception non-use, using a question adapted from existing literature. Anchor points on the 5-point Likert scale range from "I strongly agree" to "I strongly disagree". At baseline, 2 weeks, and 9-month follow-up participants will be asked about their perceived likelihood of getting pregnant/their partner pregnant if they didn't use contraception.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  6. Change in participants' sexual knowledge, as reflected by their mean scores on a sexual knowledge questionnaire.

    A change in participants' mean scores on questionnaire items assessing their sexual knowledge (STIs, pregnancy and contraception) using questions adapted from existing literature. Sexual knowledge questionnaire items completed by participants at baseline, 2 weeks, and 9-month follow-up.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  7. A change in the number of participants who visit a clinic to obtain contraception or to undergo sexually transmitted infection (STI) screening over the past 3 months.

    A change in the number of participants self-reporting visiting a clinic or doctor's office to discuss or get contraception or STI screening using a question adapted from existing literature. Participants reported at baseline, 2 weeks, and 9-month follow-up.

    Time frame: Baseline, 3-month follow-up, 9-month follow-up.

  8. Assessment of the fidelity of program delivery based on duration of No Baby No game play.

    Assessment of the mean duration that each participant plays the No Baby No game over two game-play sessions (Baseline and approximately 1 week follow-up), as captured by the video game.

    Time frame: Baseline

  9. Assessment of the fidelity of program delivery based on number of interruptions to No Baby No game play.

    Assessment of the average number of interruptions to game play per participant (number of times participant leaves the room or has to be redirected to play the game), as hand-recorded by research assistants over two gameplay sessions (Baseline and approximately 1 week follow-up).

    Time frame: Baseline

  10. Assessment of the quality of No Baby No program delivery, as indicated by the average number of technological failures during the game-play experience.

    Assessment of the average number of technological failures during No-Baby No game play (internet-, tablet- or game failures) as hand-recorded by research assistants on game-play session checklists over two game play sessions (Baseline and approximately 1 week follow-up).

    Time frame: Baseline

  11. Assessment of the quality of No Baby No program delivery, as measured by the average number of minutes of game play.

    Average number of minutes of game play across each of two game-play sessions, as captured by the No Baby No video game (Baseline and approximately 1 week follow-up).

    Time frame: Baseline

  12. Assessment of the quality of No Baby No program delivery, as measured by the average number of game play sessions attended by participants.

    Average number of game play sessions attended by participants out of a maximum total of two), as captured by the No Baby No video game (Baseline and approximately 1 week follow-up).

    Time frame: Baseline

  13. Assessment of the quality of No Baby No program receipt, as measured by participants' average satisfaction with the game-play experience.

    Assessment of participants' average satisfaction with the No Baby No gameplay experience, as rated on a 5-Point Likert scale after each of two game-play sessions (Baseline and approximately 1 week follow-up).

    Time frame: Baseline

  14. Assessment of participants' responsiveness to the No Baby No video game, as measured by their average enjoyment rating for the game.

    Assessment of participants' average response to a multiple-choice questionnaire item asking about how much they enjoyed playing the game at two gameplay sessions (Baseline and approximately 1 week follow-up). Response options to the question "I enjoyed playing the game" are on a 5-point Likert scale with anchor points of "I strongly agree" and "I strongly disagree".

    Time frame: Baseline

  15. Assessment of participants' responsiveness to the No Baby No video game, as measured by their average helpfulness rating for the game.

    Assessment of participants' average response to a multiple-choice questionnaire item asking about how helpful they found the game at two gameplay sessions (Baseline and approximately 1 week follow-up). Response options to the question "I found the game helpful" are on a 5-point Likert scale with anchor points of "I strongly agree" and "I strongly disagree".

    Time frame: Baseline

  16. Assessment of participants' responsiveness to the No Baby No video game, as measured by their average rating of connection with the characters from the game.

    Assessment of participants' average response to a multiple-choice questionnaire item asking about how connected they were to the characters in the game at two gameplay sessions (Baseline and approximately 1 week follow-up). Response options to the question "I felt connected to the characters in the game" are on a 5-point Likert scale with anchor points of "I strongly agree" and "I strongly disagree".

    Time frame: Baseline

  17. Assessment of participants' responsiveness to the No Baby No video game, as measured by their average rating of likelihood of playing the game again.

    Assessment of participants' average response to a multiple-choice questionnaire item asking how likely they would be to play the game again, if given the choice. Question completed at two gameplay sessions (Baseline and approximately 1 week follow-up). Response options to the question "I would play the game again" are on a 5-point Likert scale with anchor points of "I strongly agree" and "I strongly disagree".

    Time frame: Baseline

  18. Assessment of the acceptability of the No Baby No video game to participants, as measured by their average rating of comprehension of game content.

    Assessment of participants' average response to a multiple-choice questionnaire item asking about how easy the content of the game was to understand. Question completed at two gameplay sessions (Baseline and approximately 1 week follow-up). Response options to the question "I found the content in the game easy to understand" are on a 5-point Likert scale with anchor points of "I strongly agree" and "I strongly disagree".

    Time frame: Baseline

  19. Assessment of the acceptability of the No Baby No video game to participants, as measured by their average rating of the game's usefulness.

    Assessment of participants' average response to a multiple-choice questionnaire item asking about how useful the game was in helping participants to make real-life decisions. Question completed at two gameplay sessions (Baseline and approximately 1 week follow-up). Response options to the question "I found the game useful in helping me to make decisions in real life" are on a 5-point Likert scale with anchor points of "I strongly agree" and "I strongly disagree".

    Time frame: Baseline

  20. Qualitative assessment of the feasibility of the program delivery protocol for the No Baby No game, as evidenced by resource sufficiency.

    Assessment of whether the resources provided for game-play sessions were sufficient, as documented through meeting minutes from twice-weekly team meetings with research personnel facilitating No Baby No game-play sessions (at Baseline and approximately 1 week follow-up).

    Time frame: Baseline

  21. Qualitative assessment of facilitators and barriers to No Baby No videogame delivery (feasibility metrics).

    Assessment of facilitators and barriers to program delivery, as documented through meeting minutes from twice-weekly team meetings with research personnel facilitating No Baby No game-play sessions (at Baseline and approximately 1 week follow-up).

    Time frame: Baseline

07

Study locations

6 of 7 sites recruiting
  • Sesame Flyers International Inc.
    Brooklyn, New York 11203, United States
    Recruiting
  • El Barrio Operation Fightback
    New York, New York 10035, United States
    Recruiting
  • King of Kings Foundation
    Queens, New York 11433, United States
    Recruiting
  • New York Center for Interpersonal Development (NYCID)
    Staten Island, New York 10301, United States
    Recruiting
  • Bronx Health Link
    The Bronx, New York 10451, United States
    Not yet recruiting
  • ASPIRA
    The Bronx, New York 10454, United States
    Recruiting
  • Destination Tomorrow
    The Bronx, New York 10455, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06990724
Collaborators
Department of Health and Human Services
Responsible party
Sponsor
First posted
May 25, 2025
Start date
Jun 11, 2025
Primary completion
Nov 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Dec 22, 2025

Study contacts

Miah Roberts Miah Roberts
Contact
mir4017@med.cornell.edu
(347)366-0286
Aileen Gariepy
Contact
amg4013@med.cornell.edu
(212)746-3154
Aileen Gariepy, MD, MPH, MHS
principal investigator · Weill Medical College of Cornell University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion